| Identification | Back Directory | [Name]
3,5,9-Trioxa-4-phosphapentacosan-1-aminium,7-(acetyloxy)-4-hydroxy-N,N,N-trimethyl-10-oxo-,innersalt,4-oxide,(7R] | [CAS]
79512-78-0 | [Synonyms]
3,5,9-Trioxa-4-phosphapentacosan-1-aminium,7-(acetyloxy)-4-hydroxy-N,N,N-trimethyl-10-oxo-,innersalt,4-oxide,(7R]
3,5,9-Trioxa-4-phosphapentacosan-1-aminium,7-(acetyloxy)-4-hydroxy-N,N,N-trimethyl-10-oxo-,innersalt,4-oxide,(7R)- | [MOL File]
79512-78-0.mol |
| Hazard Information | Back Directory | [Uses]
1-Palmitoyl-2-acetyl-sn-glycero-3-phosphorylcholine is used in the mRNA combination therapy for treatment of cancer. | [Definition]
ChEBI: 1-palmitoyl-2-acetyl-sn-glycero-3-phosphocholine is a 1,2-diacyl-sn-glycero-3-phosphocholine in which the two acyl substituents at positions 1 and 2 are specified as palmitoyl and acetyl respectively. It has a role as a platelet-activating factor receptor agonist. It is functionally related to an acetic acid and a hexadecanoic acid. | [Biological Activity]
16:0-02:0 PC acts as a receptor (PAF-R) agonist. Increase in the level of phosphocholine (PC) is observed in Alzheimerμs disease. |
|
| Company Name: |
Merck KGaA
|
| Tel: |
(+86) 21 2033 8288 |
| Website: |
http://www.sigmaaldrich.cn |
|